Ceramide synthase-6 confers resistance to chemotherapy by binding to CD95/Fas in T-cell acute lymphoblastic leukemiaDattesh Verlekar(Texas Tech University), Min H. Kang(University of Southern California)Cell Death and DiseaseSeptember 11, 201810.1038/s41419-018-0964-4Cited by 38SaveCiteExport RISWatch citationsRelated PapersActivity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo|Blood|2007|155